Delivery Order SPE2DB22D6029-SPE2DB25FLVTC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,333.47 to AmerisourceBergen Drug Corp for PROMACTA 25 MG Suspension packets (30-count units) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. PROMACTA is a pharmaceutical treatment used primarily for immune...
- This is a $24,059.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROMACTA 75 MG TABLET medication, with a period of performance through May 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range...
- The Defense Logistics Agency awarded a $8,026.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of PROMACTA 50 MG tablets in units of 30s. The contract, which is not set-aside and competitively awarded, has an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,026.53 on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units). This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The delivery order is set to be completed by September...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for PROMACTA 50 mg tablets in packages of 30 units. This firm fixed-price delivery order, valued at $8,026.53, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by August 14, 2025. The award leverages AmerisourceBergen's established relationship as a critical pharmaceutical vendor within the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This award, valued at $16,053.06, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The contract is scheduled for ultimate completion by September 18, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on July 22, 2025, with a ceiling value of $24,059.26 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $24,059.26 to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count packaging) on August 25, 2025, with a completion date of September 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency Troop Support Medical awarded a $63,591 delivery order to Amerisourcebergen Drug Corporation for 50 mg tablets of Promacta. The delivery order is a firm fixed price contract for 4561740088 PROMACTA 50 MG TABLET UU 30S to be delivered to a location in Conshohocken, Pennsylvania by August 29, 2023 from a start date of August 8, 2023. As the Defense Logistics Agency supports the procurement of medical supplies and pharmaceuticals for the U.S. military, this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $12,029.63, with an ultimate completion date of August 20, 2025. The contract is not set-aside and represents a competitively awarded procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVTCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. PROMACTA is an immunosuppressant medication commonly used to treat thrombocytopenia in patients with chronic immune conditions, representing a specialized pharmaceutical product within the broader military healthcare supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As the prime contractor on this global pharmaceutical support vehicle, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contractor's extensive federal contract portfolio and demonstrated capability to fulfill diverse pharmaceutical procurement requirements through open competition underscore its critical role in the military's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 8/20/25 |